RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Signal Transduction and Targeted Therapy

Topics

Biology

Immunology

Medicine

Pathology

Infectious Diseases

Show all topics

DOI

10.1038/s41392-020-00402-5

License

CC-BY

Other Formats

PDF